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Summary
 
The dysregulated expression of interleukin 4 (IL-4) can have deleterious effects on the out-
come of infectious and allergic diseases. Despite this, the mechanisms by which naive T cells
commit to IL-4 expression during differentiation into mature effector cells remain incom-
pletely defined. As compared to cells from most strains of mice, activated CD4
 
1
 
 T cells from
BALB mice show a bias towards IL-4 production and T helper 2 commitment in vitro and in
vivo. Here, we show that this bias arises not from an increase in the amount of IL-4 produced
per cell, but rather from an increase in the proportion of CD4
 
1
 
 T cells that commit to IL-4 ex-
pression. This strain-specific difference in commitment was independent of signals mediated
via the IL-4 receptor and hence occurred upstream of potential autoregulatory effects of IL-4.
Segregation analysis of the phenotype in an experimental backcross cohort implicated a poly-
morphic locus on chromosome 16. Consistent with a role in differentiation, expression of the
phenotype was CD4
 
1
 
 T cell intrinsic and was evident as early as 16 h after the activation of na-
ive T cells. Probabilistic gene activation is proposed as a T cell–intrinsic mechanism capable of
modulating the proportion of naive T cells that commit to IL-4 production. 
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C
 
ontrol of infectious pathogens requires the maturation
of naive CD4
 
1
 
 T cells to effector cells that secrete
lymphokines critical to the coordination of the appropriate
host immune response. Different pathogens require differ-
ent responses; intracellular organisms are controlled by
CD4
 
1
 
 T cells that secrete inflammatory/activating cyto-
kines such as IFN-
 
g
 
, designated the Th1 subset, whereas
extracellular organisms, such as helminths, are controlled
by CD4
 
1
 
 T cells that secrete cytokines such as IL-4 and
IL-5, designated the Th2 subset. Left unregulated, such
cells can mediate tissue-damaging inflammatory or allergic
diseases, respectively. A number of variables influence the
type of response which predominates in a given context,
including antigen dose and mode of delivery, types of
APCs, the nature of stimulatory or costimulatory signals,
and the specific cytokines present in the developmental
microenvironment (1). Of critical importance in mediating
the appearance of Th1 or Th2 cells are the cytokines IL-12
or IL-4, respectively, as demonstrated both in vitro and in
vivo using the recombinant cytokines or neutralizing anti-
cytokine antibodies (2–6), and in mice with targeted disrup-
tion of these cytokine genes (7, 8) or the transcription fac-
tors implicated in their respective signaling pathways (9–13).
During the differentiation of naive, L-selectin
 
hi
 
 CD4
 
1
 
 T
cells, IL-4 plays a necessary early role in the generation of
IL-4–producing effector cells in vitro and in vivo (2, 3, 6).
The source of this requisite early IL-4 has been controver-
sial, although increasing evidence in various experimental
systems supports a direct contribution from CD4
 
1
 
 T cells
themselves (14, 15). Given its critical role in supporting the
generation of IL-4–producing effector cells, how expres-
sion of this early IL-4 is regulated remains an important
question.
Strain-specific differences in the ability to generate cy-
tokine-producing effector CD4
 
1
 
 T cells can be exploited
to elucidate developmental control points in the process
leading from naive T cells to mature effectors. BALB strain
mice have been shown to possess a genetic predisposition
towards the development of IL-4–producing effector T
cells (4, 5). Comparative studies between BALB and non–
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IL-4-biased strains of mice have led to the definition of
several novel levels of control in the development of ma-
ture cytokine-secreting effector cells. Murphy and co-
workers have implicated a locus on chromosome 11 in pre-
mature loss of functional IL-12 receptor expression as one
mechanism underlying the BALB strain bias (16, 17). Since
IL-12 can promote the generation of Th1 effector cells and
antagonize the Th2-promoting effects of IL-4, the acquired
inability to respond to IL-12 favors the generation of IL-4–
producing cells. Thus, temporal modulation of sensitivity
to cytokine signaling is implicated in effector T cell devel-
opment. In contrast to strain-specific differences in respon-
siveness to cytokines, a relatively late event in the differen-
tiative process, we were interested in the early processes
that affect how naive T cells initially commit to defined
patterns of cytokine expression.
Here, we show that the cellular basis for elevated IL-4
production by BALB strain CD4
 
1
 
 T cells is a novel, genet-
ically regulated developmental process that controls the
proportion of naive precursors that commit to IL-4 expres-
sion. This process is shown to be influenced, at least in part,
by a locus centromeric on chromosome 16. Analysis of re-
constituted mixed fetal liver chimeras demonstrated that
the process is intrinsic to CD4
 
1
 
 T cells. Thus, T cells main-
tain a genetically regulated mechanism that affects the
probability that naive cells will commit to IL-4 gene ex-
pression after their activation. This probability is postulated
to be relatively high in BALB-derived cells, resulting in the
initial generation of a disproportionately large number of
IL-4–expressing cells within populations of activated T
cells.
 
Materials and Methods
 
Cell Purification.
 
CD8-depleted spleen cells were prepared by
incubation of 2.5–3.0 
 
3
 
 10
 
7
 
 spleen cells/ml culture medium
(RPMI 1640 with 10% heat-inactivated FCS, 50 
 
m
 
M 2-ME, 2
mM 
 
l
 
-glutamine and penicillin/streptomycin) with anti-CD8
 
a
 
mAb (3.155; American Type Culture Collection, Rockville,
MD) and a mixture of guinea pig and rabbit complement (Cedar-
lane Labs. Ltd., Hornby, Ontario, Canada) at 37
 
8
 
C for 45 min.
Viable cells were collected by centrifugation over Ficoll. Less
than 1% of the remaining T cells were CD8
 
1
 
.
CD4-enriched T cells were prepared by antibody and comple-
ment-mediated depletion of CD8
 
1
 
 T cells and MHC class II
 
1
 
HSA
 
1
 
 B cells, macrophages, and dendritic cells. Briefly, spleen
cells in culture medium as described above were incubated with
mAbs (all from American Type Culture Collection) against
CD8
 
a
 
 (3.155), I-A
 
d,b
 
 (BP107.2.2), and heat-stable antigen (J11d)
at optimal dilutions as assessed in preliminary experiments, and
rabbit and guinea pig complement. After incubation at 37
 
8
 
C for
45 min, viable cells were recovered by centrifugation over Ficoll,
washed extensively, and counted before distribution to tissue cul-
ture wells. An aliquot of each preparation was analyzed by flow
cytometry for the percentage of CD4
 
1
 
 T cells and routinely re-
vealed populations of 
 
.
 
85% purity.
Highly purified naive (L-selectin
 
hi
 
) and memory/effector
(L-selectin
 
lo
 
) CD4
 
1
 
 T cells were prepared by sterile three-color
flow cytometric sorting using a Becton Dickinson Vantage
 
Ò
 
(Mountain View, CA). CD4-enriched populations as prepared
above were incubated at 4.0 
 
3
 
 10
 
7
 
 cells/ml in PBS containing
3% FCS at 4
 
8
 
C for 20 min with a cocktail of anti-CD4–PE
(YTS191.1; Caltag Laboratories, Inc., South San Francisco, CA),
anti-CD8
 
a
 
–FITC (CT-CD8
 
a
 
; Caltag Laboratories, Inc.), anti-
HSA–FITC (MI/69; PharMingen, San Diego, CA), and anti–
L-selectin–biotin (MEL-14; PharMingen), washed, and then
incubated again with streptavidin-APC (Molecular Probes Inc.,
Eugene, OR). The anti-CD8
 
a
 
 antibody used for complement-
mediated lysis (3.155) did not block staining by the anti-CD8
 
a
 
immunofluorescent mAb (CT-CD8
 
a
 
) used during sorting.
CD4
 
1
 
CD8–L-selectin
 
hi
 
 and –L-selectin
 
lo
 
 cells were sorted,
washed, counted, and resuspended in fresh culture media before
distribution to tissue culture wells. Where designated, TCR
V
 
b
 
8
 
1
 
, V
 
b
 
7,
 
1
 
 and V
 
b
 
2
 
1
 
 cells were depleted (
 
.
 
99%) using flow
cytometry after incubation with the appropriately labeled mAbs
(Caltag Laboratories, Inc.). Purity was confirmed by immunoflu-
orescent analysis of sorted cells, and was consistently 
 
.
 
98%. Dead
cells and debris were electronically excluded using forward- and
side-scatter characteristics.
The T cell–depleted APCs were prepared from spleen cell
populations by antibody (all from American Type Culture collec-
tion) and complement-mediated lysis with anti-Thy 1.2 (J1j.10),
anti-CD8
 
a
 
 (3.155), and anti-CD4 (RL172). Viable cells were
purified over Ficoll and irradiated with 3,000 rad before use. T cell
contamination was 
 
,
 
1% as assessed by flow cytometric analysis.
 
T Cell Stimulation with APCs.
 
Cells prepared as designated
were cultured (using 5 
 
3
 
 10
 
6
 
/ml) in triplicate microtiter wells of
multiscreen-BV plates (1.2 
 
m
 
m, low protein binding, Durapore
membrane; Millipore Corp., Bedford, MA) with anti-TCR
 
b
 
mAb (H57.597, 12.5 
 
m
 
g/ml), anti-CD28 mAb (37N51.1, 10 
 
m
 
g/
ml), and 50 U/ml recombinant human IL-2. Human CTLA4-Ig
(20 
 
m
 
g/ml) was added to block intrinsic CD28/CTLA4 ligands
from the APCs. Anti–IL-4 mAb (11B11, 20 
 
m
 
g/ml) was added
where indicated to the primary cultures. Where designated, the
primary supernatants were collected after 5 d for cytokine analy-
sis. Subsequently, cells were washed extensively in situ using a
vacuum manifold that allowed media from each of the 96 wells to
be filtered continuously through the microporous bottoms of the
wells, leaving the cells intact. These primed cells were then re-
stimulated by the addition of irradiated, T cell–depleted spleno-
cytes (APCs; 5 
 
3
 
 10
 
6
 
/well) with fresh anti-TCR
 
b
 
 mAb and IL-2.
After 48 h, the supernatants were harvested and analyzed for IL-4
by ELISA. The same results occurred if cells were collected,
counted, and redistributed to new wells using the same cell num-
bers before the secondary stimulation.
 
T Cell Stimulation without APCs.
 
Tissue culture wells were
precoated with anti-TCR (H57.597, 10 
 
m
 
g/ml) and anti-CD28
(37N51.1, 10 
 
m
 
g/ml) for 3 h at 37
 
8
 
C and then washed exten-
sively with PBS before the addition of highly purified T cells.
 
Genetic Analysis.
 
Tail DNA was prepared from a cohort of 63
C57BL/6 
 
3
 
 (C57BL/6 
 
3
 
 BALB/c) F
 
1
 
 mice using standard
methods. A series of DNA marker loci were selected to cover the
genome using markers polymorphic between C57BL/6 and
BALB/c mice that were evenly spaced over each chromosome as
identified using the Whitehead Institute for Biomedical Re-
search/MIT Center for Genome Research (Cambridge, MA) da-
tabase. Additional markers were used to saturate areas of interest
defined by prior studies (16, 18–20). The markers and amplifica-
tion methods used are available from the authors on request.
DNA marker data were assessed in three ways. First, simple 
 
t
 
 tests
contrasting mice with homozygous C57BL/6 markers against
heterozygous BALB/c 
 
3
 
 C57BL/6 markers with respect to IL-4
levels were performed. Second, likelihood-based interval map- 
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, determinant of IL-4 commitment;
HPRT, hypoxanthine phosphoribosyltransferase; QTL, quantitative trait
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ping was performed using the Quantitative Trait Locus (QTL)
 
1
 
-
Cartographer program. QTL mapping is a technique used to
identify the approximate location of genes that influence a trait
that exhibits continuous variation (21). It is particularly suited for
experimental cross analysis among inbred mouse strains, since
strains known to be polymorphic at different loci can be inter-
bred, creating informative recombinations for linkage analysis. Fi-
nally, multilocus models were assessed through multiple regres-
sion analyses (22, 23). Significance levels for the univariate
analysis results were compared according to suggested guidelines
(24).
 
Intracellular Cytokine Determination.
 
Highly purified CD4 T
cells prepared as above from BALB/c, C57BL/6, and (BALB/c 
 
3
 
C57BL/6) F
 
1
 
 mice were stimulated in the presence of 25 
 
m
 
g/ml
anti–IL-4 receptor mAb M1 (25) for 16 h in wells coated with
antibodies to TCR
 
b
 
 (H57.597, 20 
 
m
 
g/ml) and CD28 (37N51.1,
20 
 
m
 
g/ml). 3 h before harvesting, brefeldin A (10 
 
m
 
g/ml; Epi-
centre Technologies Corp., Madison, WI) was added to promote
intracellular accumulation of secreted proteins such as IL-4. Cells
were washed twice in PBS/1% FCS and then incubated on ice
for 30 min with anti-CD44–CyChrome (IM7; PharMingen). Af-
ter two washes with PBS, cells were fixed in 4% formaldehyde for
15 min and then washed two more times in PBS/1% FCS. Cells
were incubated at room temperature for 10 min in PBS/0.5% sa-
ponin and then for 30 min with anti–IL-4–PE (11B11; PharMin-
gen) diluted in PBS/0.5% saponin. Before resuspending in PBS/
1% FCS for flow cytometric analysis, cells were washed twice in
PBS/1% saponin and once in PBS/1% FCS. Controls were
stained identically, with the exception of anti–IL-4–PE, which
was preincubated for 20 min with recombinant murine IL-4.
Analysis was based upon 2 
 
3
 
 10
 
5
 
 events live-gated as based on
forward- and side-scatter characteristics.
 
Reverse Transcriptase PCR Analysis.
 
Highly purified L-selec-
tin
 
hi
 
 or L-selectin
 
lo
 
 CD4
 
1
 
 T cells from BALB/c or C57BL/6 mice
were stimulated by culture in wells precoated with anti-TCR
 
b
 
mAb (H57.597, 10 
 
m
 
g/ml) and anti-CD28 mAb (37N51.1, 10
 
m
 
g/ml), in the presence of anti–IL-4R mAb (M1, 25 
 
m
 
g/ml). Af-
ter 17 h, total RNA was extracted (RNAzol B; Biotecx Labora-
tories, Houston, TX), reverse transcribed with random hexamers
(Clontech Laboratories, Inc., Palo Alto, CA) and Moloney mu-
rine leukemia–virus reverse transcriptase (Clontech Laboratories,
Inc.), and used to template a competitive PCR assay for the pres-
ence of the constitutively expressed gene, hypoxanthine phos-
phoribosyltransferase (HPRT). Serial twofold cDNA dilutions
were performed in the presence of a constant amount of the
competitor plasmid, pQRS (26), which contains both HPRT and
IL-4 pseudogenes that amplify using the wild-type primers but
result in larger, more slowly migrating products after electro-
phoresis in ethidium bromide–stained 2.5% agarose gels.
 
Establishment of Hematopoietic Cell Chimeric Mice.
 
Embryonic
day 15 fetuses were recovered from time-mated parental BALB/c
and C57BL/6 females. Day 0 was the day of detecting a vaginal
plug. Fetal liver cell suspensions from each parental strain were
prepared in culture medium, washed, counted, and mixed in a 1:1
ratio. The mixed cells (7 
 
3
 
 10
 
6
 
 per mouse) were administered in-
travenously to reconstitute lethally irradiated (980 rads; BALB/c 
 
3
 
C57BL/6) F
 
1
 
 recipient mice. Animals were maintained in a
specific pathogen–free facility for 3–6 wk before analysis to allow
sufficient time for donor hematopoietic cells to reconstitute the
immune system of recipient mice. For analysis, cell suspensions
were prepared from the combined spleen and lymph node (cervi-
cal, axillary, brachial, inguinal and mesenteric) populations from
pools of two to three chimeric mice. In three experiments, re-
constitution favored C57BL/6-derived cells (mean percentage
C57BL/6-derived CD4
 
1
 
 T cells, 31%; mean percentage BALB/c-
derived CD41 T cells, 8%). CD41-enriched T cells were pre-
pared as described above and sorted for their expression of H-2Db
(mAb KH95; PharMingen) and H-2Dd (mAb 34-2-12; Phar-
Mingen) to distinguish C57BL/6-derived, BALB-derived, and
F1-derived (host) cells. The purified CD41 T cell populations
(.99%) were activated for 16 h in tissue culture wells precoated
with anti-TCR/CD28 mAb and IL-2 in the presence of anti–IL-
4R blockade before purification of mRNA and analysis by reverse
transcriptase PCR assay for IL-4 expression.
Results
BALB-derived CD41 T Cells Produce Elevated Levels of
IL-4. CD8-depleted spleen cells that were primed for 5 d
with anti-TCR and anti-CD28 mAb in the presence of IL-2,
then washed and restimulated under the same conditions
for 2 d, produced .40 times more IL-4 when isolated from
BALB-, as compared with B10.D2- or C57BL/6-strain
mice (Fig. 1). Inclusion of an anti–IL-4 mAb during the
priming period abolished the IL-4 recovered during the
second stimulation, in agreement with prior studies (2, 3,
6). Similar results were obtained when IL-5 was measured
in the secondary reaction, although the increases were
more variable (6–40-fold greater amounts from BALB/c T
cells in six experiments). NK1.11 CD41 T cells were not
required for these effects; depletion of Vb81, Vb71, and
Vb21 CD41 T cells, which comprise the majority of these
cells (27), did not affect IL-4 production by purified
BALB/c or C57BL/6 T cells in this assay (14.4 vs. 0.6 ng/
ml IL-4 in BALB/c or C57BL/6 cultures, respectively).
These data indicate that (a) IL-4 was being produced dur-
Figure 1. IL-4 production by CD4-enriched spleen cell populations.
Spleen cells from BALB/c (H-2d), BALB.B (H-2b), BALB.K (H-2k), and
B10.D2 (H-2d) mice were depleted of CD81 T cells and were activated
with anti-TCRb and anti-CD28 mAbs in the presence of IL-2, and in
the absence (left) or presence (right) of anti–IL-4 mAb. After 5 d, cells
were restimulated with fresh APCs, anti-TCRb mAb, and IL-2. After 48 h,
the supernatants were harvested and analyzed for IL-4 by ELISA. Results
depict means 6 SEM of triplicate determinations. C57BL/6 cells gave
results comparable to B10.D2 cells.2292 IL-4 Commitment by CD41 T cells
ing the priming period and (b) that this IL-4 was required
to support the appearance of cells capable of producing
IL-4 (and IL-5) upon restimulation. Thus, with this assay,
the high IL-4 phenotype of BALB-derived CD41 T cells
could be revealed with nontransgenic T cells from wild-
type mice.
The recovery of higher amounts of IL-4 after restimu-
lation could reflect augmented transduction of signals
through the IL-4R in BALB-derived T cells, since IL-4
might enhance its own production via Stat6-mediated tran-
scriptional activation (28). To assess this possibility, naive,
L-selectinhi CD41 T cells were purified from BALB/c and
C57BL/6 mice in which the IL-4 gene was inactivated
(29). Cells were primed in the presence of titrating
amounts of exogenous IL-4, and, after restimulation, as-
sayed for IL-5 production as an independent means of as-
sessing IL-4 responsiveness (1). Across the range of IL-4
doses tested, IL-4–deficient BALB/c cells made slightly
less, and certainly no more, IL-5 than did cells from IL-4–
deficient C57BL/6 mice (Fig. 2 A). These data suggest that
differences in IL-4R signaling efficiency were not sufficient
to explain the augmented levels of IL-4 (and IL-5) pro-
duced by restimulated BALB/c CD41 T cells.
Independent of positive feedback through IL-4R signal-
ing, TCR/CD28-mediated activation might directly stim-
ulate augmented IL-4 production from naive BALB/c
CD41 T cells. To address this possibility, naive, L-selectinhi
CD41 T cells were primed with anti-TCR/CD28 in the
presence of blocking anti–IL-4R mAb. The efficacy of the
IL-4R blockade was demonstrated by the dose-dependent
abrogation of IL-4 production upon restimulation, which
was complete at 25 mg/ml mAb. In a reciprocal fashion,
IL-4R blockade now allowed the detection of IL-4 that ac-
cumulated during priming, presumably due to the inhibi-
tion of receptor-mediated uptake of secreted IL-4. More
importantly, compared with B10.D2 or C57BL/6, BALB/c-
derived CD41 T cells produced substantially more IL-4
(Fig. 2 B and data not shown). Thus, differential IL-4 pro-
duction that occurred in direct response to activation dur-
ing priming and that was independent of signals mediated
by the IL-4R correlated with the ability of BALB/c, but
not C57BL/6 or B10.D2, CD41 T cells to differentiate
into high IL-4 producers upon secondary stimulation. This
was further supported by an analysis of IL-4 transcripts
present in these cells as early as 16 h after stimulation. Even
in the presence of saturating amounts of anti–IL-4R mAb,
highly purified naive (L-selectinhi) BALB/c CD41 T cells
contained 8–16-fold more IL-4 mRNA as compared to
C57BL/6 cells (Bix, M., and R.M. Locksley, unpublished
observations; data not shown, and see below). Since these
cells were activated by cross-linking antibodies in the
absence of APCs or exogenous cytokines, the high IL-4
production phenotype was intrinsic to L-selectinhi CD4–
enriched T cells.
IL-4 Production Is Distinct from Loss of IL-12 Responsive-
ness. Prior studies of the Th subset bias of BALB/c T cells
suggested that premature loss of IL-12 responsiveness was
responsible for the relatively low amounts of IFN-g recov-
ered from these cells after restimulation in vitro (17). To
investigate the potential relatedness of this phenomenon to
the high IL-4 phenotype, highly purified naive, L-selectinhi
CD41 T cells from BALB/c and B10.D2 mice were
primed with anti-TCR/CD28 mAb in the presence or ab-
sence of IL-4 receptor blockade (25 mg/ml anti–IL-4R
mAb). After restimulation in the presence of IL-12, the rel-
ative capacity of the cells to respond with increased pro-
duction of IFN-g was then assessed. Additional cultures
were primed twice sequentially to create more completely
differentiated Th subset populations (30). In both singly
and doubly primed cultures, responsiveness to IL-12 was
impaired among BALB/c cells, even in the presence of IL-
4R blockade (Fig. 3 and data not shown). Similarly, the IL-
12 responsiveness of B10.D2 cells remained intact, even in
Figure 2. Defining the high IL-4 phenotype in BALB/c CD41 T cells.
(A) Highly purified L-selectinhi CD41 T cells from 10th-backcross
BALB/c or C57BL/6 IL-4–deficient mice were incubated with anti-
TCRb mAb, anti-CD28 mAb, IL-2, CTLA4-Ig, and BALB/c APCs.
Murine recombinant IL-4 was added at the designated concentrations.
After 5 d, cells were washed extensively, counted, and recultured in the
presence of fresh anti-TCRb mAb, IL-2, and APCs. After 2 d, the super-
natants were collected and analyzed for IL-5 by ELISA. Results depict the
mean 6 SEM of triplicate determinations and are representative of three
comparable experiments. (B) Highly purified L-selectinhi CD41 T cells
from BALB/c or B10.D2 mice were stimulated with anti-TCRb mAb,
anti-CD28 mAb, IL-2, CTLA4-Ig, and BALB/c APCs, but in the ab-
sence or presence of anti–IL-4R mAb as designated. After 5 d, primary
supernatants were collected, and the cells were washed, counted, and re-
cultured with anti-TCRb mAb, IL-2, and APCs. After 2 d, the secondary
supernatants were collected. Both primary and secondary supernatants
were analyzed for IL-4 by ELISA. Results depict means 6 SEM of tripli-
cate determinations and are representative of three comparable experi-
ments.2293 Bix et al.
the presence of IL-4R blockade. These data indicate that
the response or nonresponse to IL-12 was expressed inde-
pendently of IL-4 produced during priming, suggesting
that the high IL-4 production phenotype represented a dis-
tinct aspect of Th subset development.
Previous genetic analysis mapped the IL-12 unrespon-
siveness phenotype to chromosome 11 near the IL-4 gene
(16). To determine whether the high IL-4 phenotype re-
vealed in our studies would be amenable to similar genetic
analysis, CD41 T cells from (BALB/c 3 C57BL/6) F1 and
parental mice were compared. The restimulated F1 cells
produced levels of IL-4 that were intermediate to those
from the parental animals (Fig. 4 A). (BALB/c 3 C57BL/6)
F1 mice were then backcrossed to the low IL-4–producing
C57BL/6 parent strain, and CD41 T cells from the 63
progeny were scored for levels of IL-4 production (Fig. 4 B).
The IL-4 distribution did not conform to that predicted for
a simple monogenic trait (50% representation by each pa-
rental phenotype). Despite this, the bimodal distribution of
IL-4 levels about the C57BL/6 (IL-4 levels ,0.5) and
(BALB/c 3 C57BL/6) F1 (IL-4 levels z1) parental levels
suggested that a small number of genes might be impli-
cated, and a genome-wide approach was undertaken using
QTL analysis.
QTL mapping relies on the cosegregation of polymor-
phic alleles at known locations throughout the genome
with hypothetical alleles at neighboring loci that influence
the trait of interest. If evidence for such cosegregation can
be found, then one can infer the existence of a trait-influ-
encing locus near the implicated marker loci (31). QTL
mapping strategies make no assumptions about the ultimate
number or location of loci influencing the trait, although
the size of the effect of each locus on the trait of interest, or
“percentage of variation explained,” will dictate the num-
ber of individuals and the number of markers required to
map the trait with some power of confidence (32). Thus,
QTL mapping designs can accommodate phenotypes of
some complexity, making it an ideal approach for many bi-
ologic phenotypes.
DNA was prepared from each of the 63 backcrossed
mice and used to screen for the inheritance of a representa-
tive set of simple sequence length DNA markers selected to
span the mouse genome. Markers were selected based on
polymorphisms between the BALB/c and C57BL/6 alleles,
Figure 3. Loss of IL-12 responsiveness segregates independently from
IL-4 production. Highly purified L-selectinhi CD41 T cells from BALB/c
and B10.D2 mice at 106 cells/ml were stimulated with anti-TCRb and
anti-CD28 mAbs and IL-2 in the presence of irradiated BALB/c APC
and human CTLA4-Ig (20 mg/ml) to block intrinsic CD28/CTLA4
ligands, and in the presence or absence of 25 mg/ml anti–IL-4R mAb as
designated. After 5 d, cells were washed extensively and recultured for 2 d
at 106 cells/ml with fresh APCs, anti-TCRb mAb, and IL-2, in the pres-
ence or absence of recombinant IL-12 (10 ng/ml). After 2 d, the superna-
tants were collected and analyzed for IL-4 and IFN-g using ELISA. Re-
sults depict the means 6 SEM of triplicate determinations and are
representative of two comparable experiments.
Figure 4. Genotypic analysis of the high IL-4 phenotype. (A) CD4-enriched spleen cells from BALB/c, C57BL/6, and (BALB/c 3 C57BL/6) F1 mice
were cultured with anti-TCR and anti-CD28 mAbs with IL-2. The supernatants were harvested 48 h after the second stimulation and were analyzed for
IL-4 by ELISA. Results depict means 6 SEM of triplicate determinations and are representative of five experiments. (B) Distribution of IL-4 production
during secondary stimulation by CD41 T cells from 63 progeny of C57BL/6 3 (BALB/c 3 C57BL/6) F1 mice. Individual mice displaying similar IL-4
levels are grouped together in bins represented as vertical columns in increasing increments of 0.5 ng/ml IL-4 (e.g., mice in the column above 1 had IL-4
levels .0.5 and #1.0). Individual mice that inherited the BALB/c D16Mit81 allele are indicated as discrete dots (•) above each vertical column. (C) In-
terval mapping with markers along the centromeric region of chromosome 16. A cohort of 63 C57BL/6 3 (BALB/c 3 C57BL/6) F1 progeny was typed
for its IL-4 phenotype and for inheritance of parental polymorphic simple sequence length markers that spanned the mouse genome. The likelihood of
inheriting a BALB/c allele at D16Mit81 correlated with the high IL-4 phenotype, with a peak lod score of 3.8 (P , 0.004). Locations of polymorphic
markers are shown at the bottom, with black horizontal bar depicting 95% confidence interval.2294 IL-4 Commitment by CD41 T cells
permitting the rapid identification of mice that had in-
herited the BALB/c allele at a given locus. By simple
univariate t tests, only three markers showed evidence for
significant or suggestive linkage. Two adjacent markers on
chromosome 16 (D16Mit81 and D16Mit73) and one on
chromosome 7 (D7Mit103) showed strong genotypic asso-
ciations with IL-4 levels. Interval mapping with 10 markers
spanning chromosome 16 resulted in a peak lod score of
3.8 (95% support interval 5 2.5 centimorgans) at the
D16Mit81 locus (Fig. 4 C). This locus alone could account
for 27% of the variation in IL-4 levels among the backcross
progeny. Multiple regression analysis involving D16Mit81
and D7Mit73 suggested that the putative D7Mit73-linked
locus had a much smaller effect on IL-4 levels than the
chromosome 16 locus (r2 for D16Mit81 locus 5 26.75; r2
for D7Mit73 5 5.76; Table 1). Taken together, these two
loci could account for one-third of the variance in IL-4
levels produced by CD41 T cells in vitro. A model positing
interaction between the two loci produced nonsignificant
results for the interaction term. No linkage to chromosome
11 (or any other chromosome) was apparent, confirming
the independence of this phenotype from the previously
described IL-12 unresponsiveness trait. Thus, a novel ge-
netic locus that contributes to Th subset bias has been iden-
tified on the centromeric portion of chromosome 16. A
second locus on chromosome 7 was suggested, albeit with
less statistical confidence.
BALB/c-specific High IL-4 Production Is Due to an Increase
in the Proportion of CD41 T Cells That Commit to IL-4 Ex-
pression. Prior studies have indicated that ,5% of CD41
T cells begin to express IL-4 after primary activation (33).
Therefore, the increased production of IL-4 by BALB/c T
cells could reflect an elevation in the proportion of cells in-
duced to express IL-4 and/or increased production from
the cells that commit to IL-4 expression. To address these
possibilities, CD4-enriched T cells were activated for 16 h
in the presence of anti–IL-4R mAb and examined for in-
tracellular IL-4 content as described previously (34). Acti-
vated, CD441, BALB/c, and C57BL/6 CD41 T cells ex-
pressed comparable levels of IL-4, as judged by the mean
fluorescence intensity of the positive cells. However, the
frequency of IL-4–containing cells was up to 10-fold higher
(range: 3–10-fold; n 5 8; P , 0.05) for BALB/c as com-
Table 1. Multiple Regression Analysis of Linked Markers with IL-4 as the Dependent Variable
Model Term Coeff. S.E. F-stat. P value r2
Noninteracting Y-intercept 3.516 0.364 93.18 ,0.001 —
D16Mit81 1.646 0.544 9.15 0.004 26.75
D7Mit103 1.075 0.568 3.58 0.065 5.76
Interacting Y-intercept 3.726 0.378 97.36 ,0.001 —
D16Mit81 2.253 0.643 12.28 0.001 27.32
D7Mit103 2.279 0.905 6.33 0.016 6.78
Interaction 21.932 1.147 2.84 0.100 2.77
Two models were fit to the data. First, one in which no interaction was assumed between the chromosome 16 and chromosome 7 loci (noninter-
acting) and second, one in which an interaction was assumed (interacting). Coeff., regression coefficient; S.E., standard error of the regression coef-
ficient; F-stat., F-statistic measuring the contribution of the term to the IL-4 variance explained; P value, probability level associated with the F-sta-
tistic; r2, percentage of the IL-4 variance explained.
Figure 5. Intracellular IL-4 expression in stimulated CD41 T cells.
CD4-enriched T cells from BALB/c and C57BL/6 mice were stimulated
in the presence of anti–IL-4R mAb (M1, 25 mg/ml) and IL-2 in wells
precoated with anti-TCRb mAb and anti-CD28 mAb. After 13 h, 10
mg/ml brefeldin A was added to promote the accumulation of secreted
proteins. After an additional 3 h of culture, the cells were stained for the
activation marker CD44 and, after permeabilization, for intracellular IL-4
content. Controls were handled identically, except that anti–IL-4–PE
mAb was incubated with recombinant murine IL-4 before use in the cell-
staining assays. Viable CD441 T cells were gated using forward and side-
scatter characteristics for their intensity of IL-4 staining (left) as compared
to staining in the presence of control reagents (right). Percentages reflect
IL-4 positive cells. MFI, mean fluorescence intensity of the IL-4 gate.
Results from one of four comparable experiments are shown.2295 Bix et al.
pared with C57BL/6 cells (Fig. 5). Furthermore, analysis of
activated CD41 T cells from (BALB/c 3 C57BL/6) F1
mice revealed an intermediate frequency of IL-4–produc-
ing cells (Bix, M., unpublished observations; data not
shown), concordant with the earlier ELISA measurements
of IL-4 production after restimulation. These data suggest
that the high IL-4 phenotype of BALB/c mice stems not
from the elevated production of IL-4 per cell, but rather
from an increase in the proportion of naive T cells that
commit to IL-4 expression after TCR activation.
BALB/c CD41 T Cells in Both the Naive, L-selectinhi and
Memory, L-selectinlo Populations Exhibit the High IL-4 Pheno-
type. The majority of helper cells that produce IL-4 express
an L-selectinlo phenotype, consistent with their existence as
memory or effector populations. The IL-4 produced by
these cells is thought to promote the generation of IL-4–
producing cells from naive, L-selectinhi CD41 T cells (35).
To determine whether the BALB strain-specific high IL-4
phenotype was indeed confined to the L-selectinlo pool, we
used a sensitive semiquantitative PCR assay to analyze the
IL-4 mRNA recovered 16 h after activation of highly puri-
fied L-selectinlo and L-selectinhi CD41 T cells (.98% pu-
rity) from BALB/c and B10.D2 mice. Consistent with
prior reports, L-selectinlo cells expressed 2,000-fold more
IL-4 transcripts than L-selectinhi cells. Despite the relative
paucity of IL-4 transcripts among the L-selectinhi cells, the
BALB strain-specific high IL-4 phenotype was evident
nonetheless in both populations as defined by their L-selec-
tin phenotypes (Fig. 6). Two observations suggested that
the detection of IL-4 transcripts in activated L-selectinhi
cells was not simply due to contamination by L-selectinlo
cells. First, even an unlikely 2% contamination would pre-
dict a maximal 50-fold, rather than a 2,000-fold, difference
in the levels of IL-4 transcripts recovered between the two
cell populations. Second, the relative difference in IL-4
transcript levels between BALB/c and B10.D2 cells was
consistently higher among cells that were L-selectinhi (8–
16-fold) as opposed to L-selectinlo (4–8-fold). Together,
these results suggest that naive, L-selectinhi CD41 T cells
can be activated by TCR/CD28 cross-linking to express
the IL-4 gene and, moreover, that the BALB strain-specific
high IL-4 phenotype is manifest within the population of
cells thought to be enriched for naive T cells.
The High IL-4 Phenotype Develops as a T Cell–autonomous
Trait. The BALB strain-specific high IL-4 phenotype
could develop in a cell-autonomous fashion or arise from
transinteractions, which impart the phenotype to BALB
cells. Such interactions might include exposure to BALB-
specific self-antigens or APC-mediated signals (36). To dis-
tinguish between these possibilities, mixed hematopoietic
cell chimeras were constructed and analyzed. Such chime-
ras allowed donor-derived hematopoietic precursor cells
from two genetically distinct parents to develop in the same
animal with equivalent exposure to transinteractions. There-
Figure 6. Expression of the high IL-4 phenotype
in highly purified L-selectinhi and L-selectinlo
CD41 T cells populations. Highly purified
L-selectinhi (A) and L-selectinlo (B) CD41 T cells
were incubated in wells precoated with anti-TCRb
and anti-CD28 mAbs, IL-2, and anti–IL-4R mAb.
After 16 h, mRNA was purified, reverse tran-
scribed, and analyzed for the presence of IL-4 tran-
scripts in relation to the expression of constitutively
expressed HPRT transcripts using competitive
PCR. Upper bands in each gel denote the amplified
competitor product, lower bands denote the au-
thentic transcript prepared from the cells indicated.2296 IL-4 Commitment by CD41 T cells
fore, any strain-specific properties that persist in the donor-
derived cells developing in the chimeric animals must re-
flect cell-autonomous expression of their distinct genetic
origins. BALB/c and C57BL/6 embryonic day 15 fetal
liver cells were used as a rich source of hematopoietic
precursors devoid of mature T cells. The liver cells were
mixed and transferred to lethally irradiated (BALB/c 3
C57BL/6) F1 mice. Animals were analyzed between 3
and 6 wk after reconstitution. Donor-derived H-2Db1d2
C57BL/6 and H-2Db2d1 BALB/c CD41 T cells were
sorted from host-derived H-2Db1d1 cells using flow cy-
tometry, and the purified cells were activated with anti-
TCR/CD28 mAb for 16 h in the presence of anti–IL-4R
mAb. Relative IL-4 mRNA content of the activated cells
was then compared using the semiquantitative PCR assay.
The chimera-derived CD41 T cells of BALB/c origin pro-
duced 8–16-fold more IL-4 mRNA after activation than
did chimera-derived CD41 T cells of C56BL/6 origin, a
difference that was similar to that seen using cells derived
from unmanipulated mice from the two parental back-
grounds (Fig. 7). These data suggest that the BALB strain-
specific high IL-4 phenotype was acquired in a CD41 T
cell–autonomous fashion, consistent with a process in-
volved with a T cell intrinsic program of differentiation.
Discussion
We have identified a novel, genetically regulated devel-
opmental process that controls the proportion of naive
CD41 T cells that commit to IL-4 expression. This process
is influenced, at least in part, by a locus centromeric on
chromosome 16 which we have designated dice (determi-
nant of IL-4 commitment). Evidence for additional genetic
complexity to this phenotype was suggested by a lesser as-
sociation with a second locus on chromosome 7 (dice-2).
Together, these two genetic regions could account for 33%
of the increased IL-4 phenotype of BALB/c CD41 T cells.
dice’s influence on IL-4 levels was independent of signals
mediated via the IL-4 receptor, and hence upstream of po-
tential autoregulatory effects of IL-4. Consistent with a pu-
tative role in effector cell differentiation, dice acted in a
CD41 T cell–intrinsic manner that was evident as early as
16 h after activation.
As shown here and elsewhere (Fig. 1) (2–6), the IL-4
produced during priming was required for the subsequent
appearance of IL-4–producing cells, and thus for Th2 lin-
eage commitment. Since dice influences the number of cells
that become IL-4 producers, and hence the total amount of
IL-4 produced by a population of CD41 T cells, dice influ-
ences the balance among Th subsets. We propose the exist-
ence of a mechanism, controlled in part by dice, that regu-
lates the probability that activated naive, L-selectinhi CD41
T cells will commit to IL-4 gene expression. This probabil-
ity is postulated to be relatively high in BALB-derived
cells, resulting in the generation of a disproportionately
large number of IL-4–expressing cells within activated T
cell populations. Although this mechanism remains specu-
lative, these data provide evidence that the amounts of IL-4
produced by naive T cells can be genetically regulated by
controlling the proportion of cells that commit to its ex-
pression. By influencing the balance of Th subsets that
might potentially be generated, such a process could mod-
ulate host susceptibility to infectious and/or autoimmune
diseases.
Several transcription factors have been implicated in Th
subset commitment. Both GATA-3 and c-maf transcripts
were present in Th2, but not Th1 clones and cells, and
were shown to activate expression of the IL-4 promoter
when overexpressed in non-T cell lines, or, in the case of
GATA-3, in Th1 cells (37, 38). These factors were identi-
fied by subtractive methods comparing cells enriched for
Th1 or Th2 commitment. Since the IL-4 commitment
phenotype (as mediated by dice, dice-2, and potentially
other genes not revealed in this analysis) was expressed in-
dependently of input from either the IL-4R or IL-12R, we
conclude that it operates upstream of events mediated by
these cytokine-regulated pathways.
Recent studies of the acquisition of cytokine profiles
during the activation of naive helper T cells have revealed
multiple patterns of cytokine gene expression that were
distinct from the canonical Th1 and Th2 subsets (33, 39–
41). When cloned under nonselective conditions (e.g., in
the absence of exogenous IL-4 or IL-12), CD41 T cells
could be identified that expressed IL-3, IL-4, IFN-g, and
GM-CSF in a variety of combinatorially assorted patterns
(31). Similar conclusions were made in an analysis of IL-2,
IL-4, IL-5, IL-10, and IFN-g (32). Studies using TCR
Figure 7. Expression of the high IL-4 phenotype in BALB/c-origin
CD41 T cells from F1 chimeric mice. T cells from irradiated, reconsti-
tuted, (BALB/c 3 C57BL/6) F1 chimeric mice that contained a mixture
of parentally derived lymphoid cells were sorted for expression of CD41
and either H-2Db (C57BL/6 origin; right) or H-2Dd (BALB/c origin;
left), but not both (F1 origin). Purified cells were incubated in wells pre-
coated with anti-TCRb and anti-CD28 mAbs, IL-2, and anti–IL-4R
mAb. After 16 h, the RNA was purified and analyzed for IL-4 expression
using the competitive PCR assay.2297 Bix et al.
transgenic CD41 T cells activated in vitro (33, 42) or in
vivo (43) showed that only a fraction of activated cells ex-
pressed any given cytokine, and that again substantial het-
erogeneity occurred in the patterns of cytokines expressed
by individual cells. With repeated activation, the overall di-
versity of cytokine profiles diminished as the proportion of
cells expressing similar patterns increased, and these pat-
terns became increasingly refractory to alterations induced
by exogenous cytokines (32). These and other studies sug-
gest that polarization of responses into effector Th1 and
Th2 phenotypes may reflect the selective expansion of cells
that express cytokine patterns probabilistically acquired
during early activation–induced differentiation. According
to such a scheme, the cytokine expression profile of mature
populations may be constrained by the initial probabilities
of expression for each particular cytokine. In accordance
with such a model, conditions that favor the outgrowth of
new populations of Th effector cells with their own distinct
cytokine profiles continue to be discovered (44, 45).
Increasingly, probabilistic gene expression has been im-
plicated in mediating alternative pathways of cellular growth
and differentiation (46). Single-cell analysis of IL-2 expres-
sion revealed a bimodal all-or-none pattern of transcription
initiation, consistent with threshold effects that must be
overcome and that are achieved only by subgroups within
the population (47). Recent reports document the apparent
independent regulation of the IL-4 alleles within CD41 T
cells, consistent with probabilistic activation of this locus
(48, 49). The identification of genetic loci that affect expres-
sion of this fundamental switch point in CD41 T cell biol-
ogy may lead to a systematic dissection of the mechanisms
regulating cytokine gene expression in developing T cells,
and provide cellular targets that might affect this expression
at early periods before effector functions become invariant.
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